Table 1 The characteristics of patients in the allograft group (Study group)
No. | Gen | Age | Status before Infection | Comorbidities | CCI | Bone defect (AORI) | Allograft Applied Site | Prosthesis | Abx in BCS | 1st stage culture | Abx in interim period |
|---|---|---|---|---|---|---|---|---|---|---|---|
1 | F | 64.5 | Revision TKA | DM | 3 | F: III T: I | Femur | United, U2 PSA | Vancomycin+ceftazidime | Staphylococcus epidermidis | Cotrimoxazole |
2 | M | 67.3 | Revision TKA | DM, HTN, CKD | 5 | F: IIB | Femur | United, U2 PSA | Vancomycin+ceftazidime | Staphylococcus aureus (OSSA) | Clindamycin |
3 | F | 79.0 | Revision TKA | DM, HTN, CAD | 5 | F: IIB | Femur | United, U2 PSA | Vancomycin+ceftazidime | Staphylococcus aureus (OSSA) | Dicloxacillin |
4 | M | 65.9 | Primary TKA | DM, HTN | 3 | F: III | Femur | Zimmer, LCCK | Vancomycin+ceftazidime | Staphylococcus aureus (OSSA) | Dicloxacillin |
5 | F | 79.0 | Primary TKA | HTN | 3 | F: III | Femur | United, U2 PSA | Vancomycin+ceftazidime | Enterococcus faecalis | Ampicillin |
6 | M | 78.2 | Revision TKA | HTN | 3 | F: I T: III | Tibia | Zimmer, LCCK | Vancomycin+ceftazidime | Enterococcus faecalis | Sodium fusidate |
7 | F | 50.4 | Revision TKA | SLE | 2 | T: IIB | Tibia | Zimmer, RHK | Vancomycin+ceftazidime | Pseudomonas aeruginosa | Ciprofloxacin |
8 | M | 63.5 | Primary TKA | DM, RA | 4 | F: III | Femur | Zimmer, LCCK | Vancomycin+ceftazidime | Serratia marcescens | Ciprofloxacin |
9 | F | 71.8 | Primary TKA | DM | 4 | F: IIB T: I | Femur | United, U2 PSA | Vancomycin+ceftazidime | Mycobacterium tuberculosis | Rifampicin+Isoniazid |
10 | F | 81.1 | Primary TKA | HTN, CVA | 5 | F: I T: IIB | Tibia | United, U2 PSA | Vancomycin+ceftazidime | Escherichia coli | Ciprofloxacin |
11 | F | 45.7 | Primary TKA | DM, HB | 2 | F: III | Femur | United, tumor prosthesis | Vancomycin+ceftazidime | Staphylococcus aureus | Dicloxacillin |
12 | F | 70.2 | Primary TKA | HTN | 3 | T: III | Tibia | Zimmer, LCCK | Vancomycin+ceftazidime | Coagulase(−) staphylococcus | Dicloxacillin, cotrimoxazole |